Viewing Study NCT04701333


Ignite Creation Date: 2025-12-25 @ 3:02 AM
Ignite Modification Date: 2026-02-13 @ 11:25 AM
Study NCT ID: NCT04701333
Status: COMPLETED
Last Update Posted: 2024-02-13
First Post: 2021-01-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Cabergoline for Lactation Inhibition After Second-Trimester Abortion or Loss
Sponsor: Stanford University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lactation Suppressed View
Keywords:

Keywords

Keyword Brief Keyword Text View
None abortion View
None intrauterine fetal demise View
None second-trimester View
None lactation View
None engorgement View